Skip to main content
Erschienen in: Journal of Cancer Education 6/2021

05.06.2020

Implementation and Impact of a Serious Illness Communication Training for Hematology-Oncology Fellows

verfasst von: Garrett T. Wasp, Amelia M. Cullinan, Mary D. Chamberlin, Christi Hayes, Amber E. Barnato, Maxwell T. Vergo

Erschienen in: Journal of Cancer Education | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Effective communication between providers and patients with serious illness is critical to ensure that treatment is aligned with patient goals. We developed and tested an implementation strategy for incorporating the previously developed Serious Illness Conversation Guide (SICG), a clinician script, into hematology-oncology fellowship training at a single US academic medical center. Between December 2017 and April 2018, we trained 8 oncology fellows to use and document the SICG. The training included associated communication skills—such as handling emotion and headlining—over 7 didactic sessions. Implementation strategies included training 4 oncology faculty as coaches to re-enforce fellows’ skills and an electronic medical record template to document the SICG. We assessed effectiveness using 4 approaches: (1) SICG template use among fellows in the 12 months following training, (2) fellow confidence pre- and post-intervention via survey, (3) performance in 2 simulated patient encounters, and (4) semi-structured interviews after 12 months. Fellows successfully implemented the SICG in simulated patient encounters, though only 2 of 6 fellows documented any SICG in the clinical practice. Most fellows reported greater confidence in their communication after training. Thematic analysis of interviews revealed the following: (1) positive training experience, (2) improved patient preference elicitation, (3) selected SICG components used in a single encounter, (4) prioritize other clinical duties, (5) importance of emotion handling skills, (6) no faculty coaching receive outside training. Despite acquisition of communication skills, promoting new clinical behaviors remains challenging. More work is needed to identify which implementation strategies are required in this learner population.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Heyland DK, Allan DE, Rocker G, Dodek P, Pichora D, Gafni A, Canadian Researchers at the End-of-Life Network (CARENET) (2009) Discussing prognosis with patients and their families near the end of life: impact on satisfaction with end-of-life care. Open Med 3:e101–e110PubMedPubMedCentral Heyland DK, Allan DE, Rocker G, Dodek P, Pichora D, Gafni A, Canadian Researchers at the End-of-Life Network (CARENET) (2009) Discussing prognosis with patients and their families near the end of life: impact on satisfaction with end-of-life care. Open Med 3:e101–e110PubMedPubMedCentral
3.
Zurück zum Zitat Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK, Prigerson HG (2008) Associations between end of life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. J Am Med Assoc 300:1665–1673. https://doi.org/10.1001/jama.300.14.1665CrossRef Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK, Prigerson HG (2008) Associations between end of life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. J Am Med Assoc 300:1665–1673. https://​doi.​org/​10.​1001/​jama.​300.​14.​1665CrossRef
7.
Zurück zum Zitat Paladino J, Bernacki R, Neville BA, Kavanagh J, Miranda SP, Palmor M, Lakin J, Desai M, Lamas D, Sanders JJ, Gass J, Henrich N, Lipsitz S, Fromme E, Gawande AA, Block SD (2019) Evaluating an intervention to improve communication between oncology clinicians and patients with life-limiting cancer. JAMA Oncol 5:801. https://doi.org/10.1001/jamaoncol.2019.0292CrossRefPubMed Paladino J, Bernacki R, Neville BA, Kavanagh J, Miranda SP, Palmor M, Lakin J, Desai M, Lamas D, Sanders JJ, Gass J, Henrich N, Lipsitz S, Fromme E, Gawande AA, Block SD (2019) Evaluating an intervention to improve communication between oncology clinicians and patients with life-limiting cancer. JAMA Oncol 5:801. https://​doi.​org/​10.​1001/​jamaoncol.​2019.​0292CrossRefPubMed
8.
Zurück zum Zitat Institute of Medicine (2015) Dying in America. National Academies Press, Washington, D.C. Institute of Medicine (2015) Dying in America. National Academies Press, Washington, D.C.
9.
Zurück zum Zitat National Committee for Quality Assurance (2018) Serious illness care: person-driven measures for accountability National Committee for Quality Assurance (2018) Serious illness care: person-driven measures for accountability
12.
Zurück zum Zitat Crabtree BF, Miller WL, Swenson MM (1999) Doing qualitative research, 2nd edn. Sage Publications, Thousand Oaks Crabtree BF, Miller WL, Swenson MM (1999) Doing qualitative research, 2nd edn. Sage Publications, Thousand Oaks
Metadaten
Titel
Implementation and Impact of a Serious Illness Communication Training for Hematology-Oncology Fellows
verfasst von
Garrett T. Wasp
Amelia M. Cullinan
Mary D. Chamberlin
Christi Hayes
Amber E. Barnato
Maxwell T. Vergo
Publikationsdatum
05.06.2020
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 6/2021
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-020-01772-8

Weitere Artikel der Ausgabe 6/2021

Journal of Cancer Education 6/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.